InvestorsHub Logo
Followers 57
Posts 11399
Boards Moderated 0
Alias Born 02/09/2009

Re: daBoze post# 55778

Friday, 11/11/2011 12:42:57 PM

Friday, November 11, 2011 12:42:57 PM

Post# of 146240
I'm happy that we don't have to rely only on NNVC's FDA process expertise. That they are working with Biologics Consulting Group (BCG) is very encouraging. It's an active collaboration for preparation of the first FDA engagements.

Read about BCG here:
http://www.biologicsconsulting.com/

Message (on first page of above site) from BCG's new president, Norman W. Baylor, Ph.D.:

After more than 20 years of service to the Food and Drug Administration, I officially begin my new career at Biologics Consulting Group as the new President and Chief Executive Officer. I am pleased to be leading a tremendously talented staff at BCG that is thoroughly knowledgeable of the FDA regulations, and the scientific and clinical evaluation of complex biologicals, pharmaceuticals, devices, and combination products. Our strong track record of advising the regulated industry to facilitate entry of safe and effective products into the market place exemplifies the culture of excellence that Dr. Kenimer has built at BCG. I would like to take this opportunity to assure you that I will continue in that same tradition, expanding the horizons of the company far across the globe, and into scientific areas that will lead to new products that will advance global public health. I enthusiastically look forward to working with all of you.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News